Emerald Advisers’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Emerald Advisers's LLY Position: Q1 2026 in Review
Emerald Advisers increased its Eli Lilly (LLY) stake by 33% in Q1 2026, buying an estimated $340K and bringing the position to 1,356 shares worth $1.25M. The position accounts for 0.04% of the portfolio, ranked #137.
Emerald Advisers first reported a position in LLY in Q2 2013 and has held it in 18 quarters since. The position peaked at $1.66M in Q3 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Emerald Advisers held 1,356 shares of Eli Lilly worth $1.25M as of Q1 2026.
- Emerald Advisers bought 335 Eli Lilly shares in Q1 2026, an estimated $340K.
- Eli Lilly made up 0.04% of Emerald Advisers's portfolio in Q1 2026, its #137 holding.
- Emerald Advisers first reported a position in Eli Lilly in Q2 2013 and has held it in 18 quarters since.
- Emerald Advisers's Eli Lilly position peaked at $1.66M in Q3 2024.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Emerald Advisers's 13F filing for Q1 2026, filed 4 May 2026.